Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $555.12 | 7 | 94.9% |
| Education | $29.99 | 1 | 5.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $414.63 | 5 | $0 (2024) |
| Allergan Inc. | $147.77 | 2 | $0 (2019) |
| Lundbeck LLC | $22.71 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $208.97 | 2 | ABBVIE INC. ($208.97) |
| 2023 | $205.66 | 3 | AbbVie Inc. ($205.66) |
| 2021 | $22.71 | 1 | Lundbeck LLC ($22.71) |
| 2019 | $117.78 | 1 | Allergan Inc. ($117.78) |
| 2018 | $29.99 | 1 | Allergan Inc. ($29.99) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $119.93 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $89.04 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $96.60 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $105.70 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.36 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2021 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.71 | General |
| Category: PSYCHIATRY | ||||||
| 09/04/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $117.78 | General |
| Category: NEUROSCIENCE | ||||||
| 07/05/2018 | Allergan Inc. | VRAYLAR (Drug) | Education | In-kind items and services | $29.99 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 64 | 484 | $74,620 | $32,523 |
| 2022 | 3 | 68 | 572 | $88,375 | $39,972 |
| 2021 | 3 | 80 | 830 | $128,995 | $60,251 |
| 2020 | 3 | 85 | 732 | $112,795 | $47,151 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 279 | $41,875 | $19,540 | 46.7% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 19 | 136 | $23,775 | $9,320 | 39.2% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 13 | 69 | $8,970 | $3,663 | 40.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 325 | $48,750 | $23,628 | 48.5% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 19 | 167 | $29,225 | $11,858 | 40.6% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 15 | 80 | $10,400 | $4,486 | 43.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 39 | 472 | $70,800 | $35,667 | 50.4% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 23 | 259 | $45,325 | $19,079 | 42.1% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 18 | 99 | $12,870 | $5,505 | 42.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 41 | 416 | $62,400 | $25,415 | 40.7% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 23 | 207 | $36,225 | $15,569 | 43.0% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 21 | 109 | $14,170 | $6,167 | 43.5% |
About Dr. Robert Burton, M.D
Dr. Robert Burton, M.D is a Psychiatry healthcare provider based in Winnetka, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1831312131.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Burton, M.D has received a total of $585.11 in payments from pharmaceutical and medical device companies, with $208.97 received in 2024. These payments were reported across 8 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($555.12).
As a Medicare-enrolled provider, Burton has provided services to 297 Medicare beneficiaries, totaling 2,618 services with total Medicare billing of $179,896. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Winnetka, IL
- Active Since 04/11/2007
- Last Updated 04/18/2023
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1831312131
Products in Payments
- VRAYLAR (Drug) $562.40
- REXULTI (Drug) $22.71
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.